为了优化枸杞叶多糖(lycium barbarum leaf polysaccharide,LBP)的提取工艺并探究LBP对小鼠过敏性鼻炎的免疫调节作用,构建卵清蛋白(ovalbumin, OVA)诱导的过敏性鼻炎模型,并给过敏性鼻炎小鼠灌胃优化工艺后得到的LBP。将30只雌性C57BL/6小鼠随机分为对照组,过敏性鼻炎模型组,LBP干预过敏性鼻炎组。从小鼠的常规状态,鼻黏膜组织化学染色以及脾脏Th1/Th2细胞比例3个方面评价LBP对小鼠过敏性鼻炎的调节作用,苏木精-伊红染色观察鼻黏膜的组织结构,过碘酸-希夫染色观察杯状细胞增生程度,甲苯胺蓝观察肥大细胞脱颗粒现象,髓过氧化物酶染色嗜酸性粒细胞的浸润程度。结果表明,枸杞叶多糖提取最佳条件为:提取时间8 h,温度50 ℃,料液比1∶25(g∶mL),LBP灌胃后的过敏性鼻炎小鼠常规状态改善,鼻黏膜炎症细胞的浸润程度减轻,脾脏Th1细胞比例升高,Th2细胞比例下降。
[1] BROZ、EK J L, BOUSQUET J, AGACHE I, et al.Allergic rhinitis and its impact on asthma (ARIA) guidelines-2016 revision[J].The Journal of Allergy and Clinical Immunology,2017,140(4):950-958.
[2] EMERYK A, EMERYK-MAKSYMIUK J, JANECZEK K.New guidelines for the treatment of seasonal allergic rhinitis[J].Postepy Dermatol Alergol,2019,36(3):255-260.
[3] HAN M W, KIM S H, OH I, et al.Serum IL-1β can be a biomarker in children with severe persistent allergic rhinitis[J].Allergy Asthma Clin Immunol,2019;15:58.
[4] TAI E L M, LOONG L J, MADHUSUDHAN P, et al.Tear cytokine levels in allergic rhinitis without ocular symptoms[J].Canadian Journal Ophthalmology,2019,54(5):635-639.
[5] FAN X H, CHENG L, YAN A H.Ameliorative effect of acetylshikonin on ovalbumin (OVA)-induced allergic rhinitis in mice through the inhibition of Th2 cytokine production and mast cell histamine release[J].APMIS,2019,127(10):688-695.
[6] REN M Y, TANG Q, CHEN F, et al.Mahuang fuzi xixin decoction attenuates TH1 and TH2 responses in the treatment of ovalbumin-induced allergic inflammation in a rat model of allergic rhinitis[J].J Immunol Res,2017,2017:8 254 324.
[7] KIM H I, KIM J K, KIM J Y, et al.Fermented red ginseng and ginsenoside Rd alleviate ovalbumin-induced allergic rhinitis in mice by suppressing IgE, interleukin-4, and interleukin-5 expression[J].Journal of Ginseng Research,2019,43(4):635-644.
[8] KAR M, BAYAR MULUK N, BAFAQEEH S A, et al.Consensus on the methodology for experimental studies in allergic rhinitis[J].International Journal of Pediatric Otorhinolaryngology,2019,121:68-71.
[9] OKANO M.Mechanisms and clinical implicatons of glucocorticosteroids in the treatment of allergic rhinitis[J].Clinical and Experimental Immunology,2009,158(2):164-173.
[10] MASCI A, CARRADORI S, CASADEI M A, et al.Lycium barbarum polysaccharides:Extraction, purification, structural characterisation and evidence about hypoglycaemic and hypolipidaemic effects:A review [J].Food Chemistry,2018,254:377-389.
[11] GAO Y, WEI Y, WANG Y, et al.Lycium barbarum:A traditional chinese herb and a promising anti-aging agent[J].Aging Disease,2017,8(6):778-791.
[12] HSIEH F C, HUNG C T, CHENG K C, et al.Protective effects of Lycium barbarum extracts on UVB-induced damage in human retinal pigment epithelial cells accompanied by attenuating ROS and DNA damage[J].Oxidative Medicine and Cellular Longevity,2018,2018:4 814 928.
[13] DING Y, YAN Y, CHEN D, et al.Modulating effects of polysaccharides from the fruits of Lycium barbarum on the immune response and gut microbiota in cyclophosphamide-treated mice [J].Food Function,2019,10(6):3 671-3 683.
[14] 张玉,韩佳利.法舒地尔对变应性鼻炎小鼠鼻黏膜中Th1/Th2、Th17/Treg相关细胞因子的影响[J].中国医科大学学报,2020,49(7):593-596.
ZHANG Y, HAN J L.Effects of fasudil on Th1/Th2 and Th17/treg related cytokines in nasal mucosa of mice with allergic rhinitis [J].Journal of China university of medical science,2020,49(7):593-596.
[15] CUI F, SHI C L, ZHOU X J, et al.Lycium barbarum polysaccharide extracted from Lycium barbarum leaves ameliorates asthma in mice by reducing inflammation and modulating gut microbiota[J].Journal of Medicinal Food,2020,23(7):699-710.
[16] YANG Q, LI C, WANG W, et al.Infiltration pattern of gammadelta T cells and its association with local inflammatory response in the nasal mucosa of patients with allergic rhinitis[J].Int Forum Allergy Rhinol,2019,9(11):1 318-1 326.
[17] ELWANY S, SHEWEL Y, BAZAK R, et al.Quitting smoking reverses nasal mucosal changes[J].Eur Arch Otorhinolaryngol,2020,277(6):1 691-1 698.
[18] STOOP A E, VAN DER HEIJDEN H A, BIEWENGA J, et al.Eosinophils in nasal polyps and nasal mucosa:An immunohistochemical study[J].J Allergy Clin Immunol,1993,91(2):616-622.
[19] KIM C H, SONG K S, KIM S S, et al.Expression of MUC5AC mRNA in the goblet cells of human nasal mucosa[J].Laryngoscope,2000,110(12):2 110-2 113.
[20] MCGUCKIN M A, HASNAIN S Z.Goblet cells as mucosal sentinels for immunity[J].Mucosal Immunol,2017,10(5):1 118-1 121.
[21] REN C, DOKTER-FOKKENS J, FIGUEROA L S, et al.Lactic acid bacteria may impact intestinal barrier function by modulating goblet cells[J].Mol Nutr Food Res,2018,62(6):e1 700 572.
[22] WANG Y, XU J, MENG Y, et al.Role of inflammatory cells in airway remodeling in COPD[J].International Journal of Chronic Obstructive Pulmonary Disease,2018,13:3 341-3 348.
[23] CRUSE G, BRADDING P.Mast cells in airway diseases and interstitial lung disease[J].Eur J Pharmacol,2016,778:125-138.
[24] DA S E Z, JAMUR M C, OLIVER C.Mast cell function:A new vision of an old cell[J].J Histochem Cytochem,2014,62(10):698-738.
[25] REN H L, LI J D, YUE F S, et al.Nasal cytology with emphasis on mast cells can improve the diagnosis and treatment of chronic rhinosinusitis[J].Chin Med J (Engl),2019,132(18):2 237-2 241.
[26] RAVIN K A, LOY M.The eosinophil in infection[J].Clin Rev Allergy Immunol,2016,50(2):214-227.
[27] MATUCCI A, VULTAGGIO A, MAGGI E, et al.Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?[J].Respir Res,2018,19(1):113.
[28] AKUTHOTA P, WANG H, WELLER P F.Eosinophils as antigen-presenting cells in allergic upper airway disease[J].Curr Opin Allergy Clin Immunol,2010,10(1):14-19.
[29] KAY A B.The role of eosinophils in the pathogenesis of asthma[J].Trends Mol Med,2005,11(4):148-152.
[30] TASHKIN D P, WECHSLER M E.Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease [J].International Journal of Chronic Obstructive Pulmonary Disease,2018,13:335-349.
[31] JEON W Y, SHIN I S, SHIN H K, et al.Samsoeum water extract attenuates allergic airway inflammation via modulation of Th1/Th2 cytokines and decrease of iNOS expression in asthmatic mice[J].BMC Complement Altern Med,2015,15:47.
[32] MOSS R B, MOLL T, EL-KALAY M, et al.Th1/Th2 cells in inflammatory disease states:Therapeutic implications[J].Expert Opin Biol Ther,2004,4(12):1 887-1 896.
[33] RAPHAEL I, NALAWADE S, EAGAR T N,FORSTHUBER T G.T cell subsets and their signature cytokines in autoimmune and inflammatory diseases[J].Cytokine,2015,74(1):5-17.